PF-03716556 Size:2mg solid SAM486A treatment resulted in the

SAM486A treatment resulted in the rapid accumulation of proapoptotic proteins p53 and Mdm2

InChi: InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5

Small-molecule activation of neuronal cell fate

Smiles: [O-][N+](=O)C1C=CC(=CC=1)NC1N=C(N=C(N=1)N1CCOCC1)N1CCOCC1

PF-03716556 Size:2mg solid SAM486A treatment resulted in thePF 03716556 is a potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease. PF 03716556 demonstrated 3 fold greater inhibitory activity than revaprazan. PF 03716556 did not display any species differences, exhibiting highly selective profile including the canine kidney Na(+), K(+) ATPase. Kinetics experiments revealed that PF 03716556 has a competitive and reversible mode of action. Product information CAS Number: